A randomized, placebo-controlled trial shows that a new drug can reduce the atrophy of the brain, which is a hallmark of multiple sclerosis. …read more
A randomized, placebo-controlled trial shows that a new drug can reduce the atrophy of the brain, which is a hallmark of multiple sclerosis. …read more